Changes to the Guidance document Temporary authorisation of human medicinal products
7. Juni 2024 – Medicinal products for identifying, preventing or treating a disease that is life-threatening or could result in disability can be authorised temporarily by Swissmedic. Application of the fast-track procedure for temporary authorisations enables medicinal products with a major therapeutic benefit to be made available to affected patients more quickly.
For more information, see here.